172 related articles for article (PubMed ID: 6173157)
1. Termination of early gestation with (15S)-15-methyl prostaglandin F2 alpha methyl ester vaginal suppositories.
Marrs RP; Brenner PF; Roy S; Mishell DR
Contraception; 1981 Dec; 24(6):617-30. PubMed ID: 6173157
[TBL] [Abstract][Full Text] [Related]
2. Termination of very early pregnancy by vaginal suppositories-(15S)-15-methyl prostaglandin F2 alpha methyl ester.
Wan LS; Stiber AJ; Turkel J
Contraception; 1981 Dec; 24(6):603-15. PubMed ID: 6173156
[TBL] [Abstract][Full Text] [Related]
3. Termination of early gestation with 9-deoxo-16,16-dimethyl-9-methylene prostaglandin E2.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1982 Sep; 26(3):261-77. PubMed ID: 6184197
[TBL] [Abstract][Full Text] [Related]
4. Post-conceptional induction of menses with a single vaginal suppository of (15S)-15-methyl prostaglandin F2 alpha methyl ester.
Scher J; Jeng DY; Kerenyi TD
Prostaglandins; 1980 Sep; 20(3):469-79. PubMed ID: 6252575
[TBL] [Abstract][Full Text] [Related]
5. Termination of early gestation with a single vaginal suppository of (15S)-15-methyl-prostaglandin F2alpha methyl ester.
Roy S; Brenner PF; Marrs RP; Mishell DR
Contraception; 1980 Aug; 22(2):137-52. PubMed ID: 7449379
[TBL] [Abstract][Full Text] [Related]
6. Methods to determine success of attempts to terminate early gestation pregnancies with prostaglandin vaginal suppositories.
Brenner PF; Marrs RP; Roy S; Mishell DR
Contraception; 1983 Aug; 28(2):111-24. PubMed ID: 6196152
[TBL] [Abstract][Full Text] [Related]
7. Postconceptional induction of menses with double prostaglandin F2 alpha impact.
Borten M; Friedman EA
Am J Obstet Gynecol; 1984 Dec; 150(8):1006-7. PubMed ID: 6507528
[TBL] [Abstract][Full Text] [Related]
8. Effect of 15(s)15-methyl-PGF2alpha-methyl ester vaginal suppositories on circulating hormone levels in early pregnancy.
Puri CP; Laumas V; Agarwal N; Zoremthangi ; Hingorani V; Laumas KR
Prostaglandins; 1977 Feb; 13(2):363-73. PubMed ID: 847240
[TBL] [Abstract][Full Text] [Related]
9. Termination of early pregnancy by a single-dose 3.0 mg 15-methyl PGF2alpha methyl ester vaginal suppository.
Mandelin M
Prostaglandins; 1978 Jul; 16(1):143-52. PubMed ID: 704921
[TBL] [Abstract][Full Text] [Related]
10. Menses induction and second-trimester pregnancy termination using a polymeric controlled release vaginal delivery system containing (15S)15-methyl PGF2 alpha methyl ester.
Bygdeman M; Christenssen N; Gréen K; Vesterqvist O; Roseman TJ; Tuttle ME; Spilman CH
Contraception; 1983 Feb; 27(2):141-51. PubMed ID: 6303690
[TBL] [Abstract][Full Text] [Related]
11. The effect of a 15(S)-15-methyl prostaglandin F2 alpha (methyl ester) suppository upon termination of early pregnancy.
Roux JF; Southern E; Gutknecht G
Contraception; 1980 Jul; 22(1):57-61. PubMed ID: 7418407
[TBL] [Abstract][Full Text] [Related]
12. Vaginal administration of 15-methyl-PGF2 alpha methyl ester for preoperative cervical dilatation. Task force on prostaglandins for fertility regulation. The World Health Organization.
Contraception; 1981 Mar; 23(3):251-9. PubMed ID: 7016432
[TBL] [Abstract][Full Text] [Related]
13. Interruption of pregnancy with vaginal suppositories containing 16,16-dimethyl-trans-delta 2-prostaglandin E1 methyl ester.
Wagatsuma T; Tabuchi T; Tabei T; Kaku R
Contraception; 1979 Jun; 19(6):591-7. PubMed ID: 487809
[TBL] [Abstract][Full Text] [Related]
14. Abortifacient effect and uterine cervix-dilating action of 16, 16-dimethyl trans delta 2 PGE1 methyl ester (ONO 802) in the form of a vaginal suppository (a randomized, double-blind, controlled study in the second trimester of pregnancy).
Sakamoto S; Satoh K; Nishiya I; Kunimoto K; Chimura T; Oda T; Takeuchi S; Satoh Y; Iizuka R; Kobayashi T; Takagi S; Yoshida T; Tomoda Y; Ninagawa T; Kurachi K; Tanizawa O; Tojo S; Mochizuki M; Maeda K; Tominaga Y; Torigoe T; Koresawa M; Taki I; Hamada T
Prostaglandins Leukot Med; 1982 Sep; 9(3):349-61. PubMed ID: 6752961
[TBL] [Abstract][Full Text] [Related]
15. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
Lauersen NH; Wilson KH
Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial on termination of early pregnancy with RU486 in combination with prostaglandin.
Wu S; Gao J; Wu Y; Wu M; Fan H; Yao G; Zheng S; Wang P; Du M; Huang Z
Contraception; 1992 Sep; 46(3):203-10. PubMed ID: 1451516
[TBL] [Abstract][Full Text] [Related]
17. The use of 16-16 dimethyl trans delta 2 PGE1 methyl ester (ONO 802) vaginal suppositories for the termination of early pregnancy. A comparative study.
Smith SK; Baird DT
Br J Obstet Gynaecol; 1980 Aug; 87(8):712-7. PubMed ID: 7426533
[TBL] [Abstract][Full Text] [Related]
18. Mid-trimester abortion by vaginal administration of 9-deoxo-16, 16-dimethyl-9-methylene-PGE2.
Bygdeman M; Christensen N; Gréen K; Lundström V
Contraception; 1980 Aug; 22(2):153-64. PubMed ID: 7449380
[TBL] [Abstract][Full Text] [Related]
19. Early pregnancy interruption with two 15-ME-PGF2a suppositories.
Lauersen NH; Wilson KH
Contraception; 1980 Mar; 21(3):273-82. PubMed ID: 7389352
[TBL] [Abstract][Full Text] [Related]
20. Low-dose prostaglandin E2 analogue for cervical dilatation prior to pregnancy termination.
Borten M; DiLeo LA; Friedman EA
Am J Obstet Gynecol; 1984 Nov; 150(5 Pt 1):561-5. PubMed ID: 6496588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
